About Us
Ace Biopharm company profile, an API distribution specialist
Company Profile
Better Ingredients Make
Better Medicines.
Since our founding in 2004, Ace Biopharm Co., Ltd. has driven excellence across pharmaceutical API distribution and nutraceutical manufacturing.
With 248 cumulative DMF registrations (as of August 2026) and KRW 127.7 billion (Approx. ~$100M USD) in revenue for 2025.
Leading Innovation in
Pharma & Biotech
In collaboration with our global partners, we support our clients throughout the pharmaceutical development journey, from early-stage development to successful commercialization.
We finally deliver efficient and competitive CDMO solutions.
We develop and manufacture high-value ingredients, including Vitamin K2 and probiotics, to world-class standards, leveraging our in-house R&D expertise.
